Renal Cell Carcinoma Diagnostics

Measuring the Radiation Exposure Risk of 89Zr for PET/CT Imaging
For patients with clear cell renal cell carcinoma (ccRCC), 89Zr-girentuximab (89Zr) is emerging as a popular radionuclide to use in positron emission tomography/computed tomography (PET/CT) imaging. While the ZIRCON study previously evaluated its performance in the detection of ccRCC, safety procedures for health care providers working with the radionuclide have not yet been established. ...
Advertisement
Advertisement

Video Insights

Conferene Coverage

Knowledge Hub Spotlight

Renal Cell Carcinoma
Renal Cell Carcinoma
Advertisement
Section Editor

Advertisement
Get the latest RCC research straight to your inbox.